October 24 | 12:05–12:50pm Industry Theater 1, Exhibit Hall, Level 1
AUVELITY: A Rapid-Acting Antidepressant That Modulates Both Glutamatergic and Monoaminergic Pathways
Overview
This branded symposium will highlight the current unmet needs in MDD and present a treatment option with rapid symptom improvement for adult patients with MDD.